Infinity Pharmaceuticals Financial Indicators Patterns

INFI -- USA Stock  

USD 1.76  0.29  14.15%

We strongly advise you to harness analysis of Infinity Pharmaceuticals fundamentals to see if markets are presently mispricing the organization. We found thirty-four available reported financial drivers for Infinity Pharmaceuticals which can be compared to its competitors. To make sure the equity is not overpriced, please check out all Infinity Pharmaceuticals fundamentals including its Shares Owned by Institutions, Net Income, Earnings Per Share, as well as the relationship between Price to Sales and Current Ratio . Please also validate Infinity Pharmaceuticals Price to Earning to confirm the company can sustain itself down the road.Use Infinity Pharmaceuticals to protect against small markets fluctuations. The stock experiences very speculative upward sentiment.. Check odds of Infinity Pharmaceuticals to be traded at $1.672 in 30 days

Infinity Pharmaceuticals Valuation Over Time

Enterprise Value

Infinity Pharmaceuticals Company Summary

Infinity Pharmaceuticals competes with NantKwest, DelMar Pharmaceuticals, Dimension Therapeutics, Denali Therapeutics, and VBI Vaccines. Infinity Pharmaceuticals, Inc., a biopharmaceutical company, develops medicines for people with cancer in the United States. Infinity Pharmaceuticals, Inc. is headquartered in Cambridge, Massachusetts. Infinity Pharmaceuticals operates under Biotechnology classification in USA and traded on NASDAQ. It employs 22 people.

Infinity Pharmaceuticals Number of Employees vs Cash Flow from Operations

Infinity Pharmaceuticals is rated below average in number of employees category among related companies. It is rated below average in cash flow from operations category among related companies .

Infinity Pharmaceuticals Systematic Risk

null. The output start index for this execution was zero with a total number of output elements of zero. The Beta measures systematic risk based on how returns on Infinity Pharmaceuticals correlated with the market. If Beta is less than 0 Infinity Pharmaceuticals generally moves in the opposite direction as compared to the market. If Infinity Pharmaceuticals Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Infinity Pharmaceuticals is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Infinity Pharmaceuticals is generally in the same direction as the market. If Beta > 1 Infinity Pharmaceuticals moves generally in the same direction as, but more than the movement of the benchmark. View also all equity analysis or get more info about beta statistic functions indicator.

Distress Rating

Infinity Pharmaceuticals Financial Distress Probability
78% 

Chance of Financial Distress

Infinity Pharmaceuticals has more than 78 (%) percent chance of experiencing financial distress in the next 2 years of operations. More Info

Infinity Pharmaceuticals Thematic Clasifications

Active Themes That Utilize Infinity Pharmaceuticals
This Stock does not participate in any thematic ideas. You can create a thematic portfolio hereView All Thematic Ideas

Growth

Infinity Pharmaceuticals Growth Changes

EPS Diluted Growth

EPS Growth

NCFO Growth

Compare

Compare Infinity Pharmaceuticals To Peers

Opportunity Range

June 23, 2018 Opportunity Range
Please also check Risk vs Return Analysis. Please also try Watchlist Optimization module to optimize watchlists to build efficient portfolio or rebalance existing positions based on mean-variance optimization algorithm.